Coming May 2025
Get Early Access
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
© aVenture Investment Company, 2025. All rights reserved.
44 Tehama St, San Francisco, CA 94105
aVenture Investment Company ("aVenture") is an independent venture capital research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals.
While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision.
aVenture does not offer investment advisory services and is not registered as an investment adviser. The data provided by aVenture does not constitute recommendations or advice, whether by methodology or a statement written by a staff member of aVenture.
Links to external websites do not imply endorsement or affiliation with aVenture. References or links to providers offering the ability to invest in a primary or secondary transaction in a company are for convenience purposes only. They are not solicitations or offers to buy or sell an investment. Remember that past performance does not guarantee future results, and venture capital and private assets should be a contributory part of a diversified portfolio.
11 employees
Agathos Biologics: A biotech firm innovating transformative science with strong ethics.
HQ
Founded
2016
Founded with a commitment to ethical innovation, Agathos Biologics is a biotechnology company focused on developing transformative scientific solutions. The company's core mission is to advance "Good Science without compromise," ensuring that their work adheres to high ethical standards. Agathos Biologics offers a range of services including custom AAV (Adeno-Associated Virus) production, analytical services, and proprietary cell lines like AE1-BHK. Their market focus spans various sectors in biotechnology, aiming to provide cutting-edge solutions for complex biological challenges.
Agathos Biologics has garnered attention for its strong ethical framework and impactful scientific contributions. The management team comprises experienced professionals dedicated to fostering innovation with integrity. Notable achievements include the development of advanced cell lines and custom viral vectors that have significant implications for gene therapy and other medical applications. The company's emphasis on ethical practices has set a benchmark in the biotech industry, promoting responsible science that aims to improve global health outcomes.
Operating Status
Active
Main Product(s)
Cell Lines, AAV
Technology
Biotech
Model Types
Services
Revenue Type(s)
Consulting
Customer Type(s)
Enterprise
Geographic Exposure
Global
When was Agathos Biologics founded?
Agathos Biologics was founded in 2016.
Where is Agathos Biologics's headquarters located?
Agathos Biologics's headquarters is located in Fargo, ND, US.
When was Agathos Biologics's last funding round?
Agathos Biologics's most recent funding round was for $900k (USD) in August 2021.
How many employees does Agathos Biologics have?
Agathos Biologics has 11 employees as of Feb 4, 2024.
How much has Agathos Biologics raised to-date?
As of July 05, 2023, Agathos Biologics has raised a total of $900k (USD) since Aug 30, 2021.
Add Comparison
Total Raised to Date
$900k
USD
Last Update Aug 30, 2021
Last Deal Details
$900k
USD
Aug 30, 2021
Grant
Current Employees
11
Last updated: Feb 4, 2024
No location information available for this company.
Locations
Source(s): This page includes data and analysis provided by the company, OpenAI, and our research analysts